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Abstract
Background
Respiratory diseases, including pneumonia, are the second largest cause of under-five mor-
tality in Mongolia and the most common cause of childhood hospitalization. However infor-
mation regarding the contribution of Streptococcus pneumoniae to pneumonia causation in
Mongolia is limited. We aimed to describe the epidemiology of hospitalized children aged
2–59 months with pneumonia, enrolled into a surveillance program in the period prior to
pneumococcal conjugate vaccine (PCV) introduction, in Mongolia.
Methods
An expanded pneumonia surveillance program enrolled children, who met the surveillance
case definition, at participating hospitals, between April 2015 and May 2016. Cumulative
incidence rates were calculated by district for all pneumonia endpoints using district specific
denominators from the Mongolian Health Department census for 2016. Socio-economic
and disease-associated factors were compared between districts using chi-squared tests.
Results
A total of 4318 eligible children with pneumonia were enrolled over the 14 month period.
Overall the incidence for all-cause pneumonia in children aged 12–59 months was 31.8 per
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1000 population; children aged 2–11 months had an almost four-fold higher incidence than
children aged 12–59 months.
Differences were found between districts with regards to housing type, fuel used for cook-
ing, hospital admission practices and the proportions of severe and primary endpoint
pneumonia.
Discussion
This study shows a high burden of pneumonia in children aged 2–59 months in Mongolia
prior to PCV introduction. Rates differed somewhat by district and age group and were influ-
enced by a number of socio-economic factors. It will be important to consider these differ-
ences and risk factors when assessing the impact of PCV introduction.
Introduction
Ninety-five percent of all deaths from acute lower respiratory tract infections occur in low-
and middle-income countries [1] with more than three quarters of childhood deaths from
pneumonia occurring in the first two years of life [2]. Respiratory diseases, including pneumo-
nia, are the second largest cause of infant and under-five mortality in Mongolia and the most
common cause of childhood hospitalization [3]. This is not surprising considering the
extremely cold winter temperatures and high levels of air pollution in urban areas [4]. In 2015,
the under-5 mortality rate in Mongolia was reported as 18.3/1000 live births [3] with all respi-
ratory disease accounting for 15% of infant deaths in children under 5 years.
Pneumonia is caused by a number of infectious agents; the most common causes being
Streptococcus pneumoniae, Haemophilus influenzae type b and respiratory syncytial virus.
Information regarding the proportional contribution of various etiological agents to pneu-
monia in Mongolia is limited. In 2000, it was estimated that globally around 800,000 children
<5 years of age died from pneumococcal disease, with 47,300 of these deaths occurring in the
Western Pacific region [5].
Studies have identified a number of risk factors for childhood pneumonia [6]. Definite risk
factors include malnutrition, non-exclusive breastfeeding during the first 4 months of life,
indoor air pollution and crowding; likely risk factors include parental smoking and concomi-
tant diseases; and possible risk factors include low maternal education, day-care attendance
and outdoor air pollution.
Mongolia introduced the 13-valent pneumococcal conjugate vaccine (PCV13) from the 1st
June 2016 accompanied by an enhanced hospital-based pneumonia surveillance program [7].
In this paper we present the baseline incidence rates and characteristics of children 2–59
months of age with pneumonia, who were enrolled into the surveillance program prior to
PCV13 introduction (April 2015-May 2016) in Mongolia. We also describe and compare the
characteristics of districts identified for different phases of PCV13 introduction. There is a
need to document the burden of pneumonia in the pre-PCV era due to a lack of data in the
region and to assist in the interpretation of changes that occur following vaccine introduction.
Methods
Study setting
PCV13 was introduced in a phased manner into the routine immunization program at 2, 4
and 9 months of age, with a catch-up campaign to 24 months of age. As previously described
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four districts of the capital city, Ulaanbaatar, were planned for initial introduction [7]. The two
“phase 1” districts (Songinokhairkhan and Su¨khbaatar) had PCV introduced from June 2016,
while the “phase 2” districts were staggered (Bayanzu¨rkh had vaccine introduced from 1st July
2017 and Chingeltei in March 2018). Hospital-based pneumonia surveillance for children
2–59 months was expanded in these four districts from April 2015. It was modified from the
routine World Health Organization Invasive Bacterial Vaccine Preventable Disease (WHO
IB-VPD) Surveillance Network that was initiated in 2007 [8].
Study population and design
Cases included children 2–59 months of age admitted with pneumonia at one of the four par-
ticipating district hospitals, or the tertiary hospital if they resided in one of the relevant dis-
tricts. Cases who met the surveillance case definition were enrolled from April 2015 to May
2016. A retrospective chart review was also conducted to ensure that all cases of pneumonia
were included in the surveillance program. Protocol details have been previously published
[7].
The study case report form (CRF) was based on the pre-existing WHO IB-VPD CRF. The
CRF included information on demographic variables, presenting symptoms and signs, previ-
ous medication, immunization history, oxygen saturation and therapy and treatment received.
In addition, a risk factor questionnaire was also completed. Blood cultures were collected for
suspected pneumonia and sepsis cases and nasopharyngeal swabs were collected, handled and
transported according to WHO recommended methods [9] for all enrolled cases who
consented.
Case definitions and study outcomes
The pneumonia study endpoints included in our analysis were WHO-defined primary end-
point pneumonia (PEP) [10] as the primary outcome, and severe pneumonia and very severe
pneumonia as the secondary outcomes (Table 1). Other secondary outcomes, related to pneu-
monia and carriage, that are part of the broader vaccine impact evaluation are described in a
previous publication [7] and are not discussed.
Statistical analysis
We calculated cumulative incidence rates (IRs) stratified by age group and district for all pneu-
monia endpoints using district specific denominators from the Mongolian Health Department
census for 2016. As there were no separate population data for infants <2 months of age, we
assumed this age group included 2/12 of the population <1 year of age. This calculated num-
ber was subtracted from the population denominator for children aged<1 year to estimate a
denominator for the 2–11 month age group. Confidence intervals for incidence estimates were
calculated using a Poisson distribution.
As chest X-rays (CXRs) were missing for retrospectively collected data, we used multiple
imputation to estimate the presence or absence of PEP for the cases who did not have CXRs
done. The predictors for the multiple imputation model (S1 Text) were based on those factors
that differed significantly between patients with and without positive CXR findings (S1 Table).
To determine whether there were differences between pneumonia cases who had PEP detected
on CXR and those who had no abnormalities detected on CXR we compared characteristics
and risk factors between these two groups using logistic regression. Variables with a p-value
<0.20 on univariate analysis were included in the model for multivariable analysis to estimate
adjusted odds ratios. All non-significant factors (assessed at p-value >0.05) were dropped
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from the multivariable model employing stepwise regression starting with predictors with the
highest p-values.
To determine if there were differences between phase 1 and phase 2 districts we compared
socio-economic and disease-associated factors in children resident in these districts using a
chi-squared test. Statistical analysis was implemented using Stata version 14.2 and version 15.1
(StataCorp LP, College Station, TX, USA).
Ethical considerations
The protocol was approved by the Human Research Ethics committees of the Mongolian Min-
istry of Health and Sports, Ulaanbaatar, the Royal Children’s Hospital, Melbourne (HREC
33203A), and the Ethics Review Committee of the World Health Organization Western Pacific
Regional Office. Written informed consent was obtained from the caregivers of all
participants.
Results
From a total of 9559 children who were admitted with any respiratory disease between April
2015 and May 2016, and were screened for the study, approximately half (4540, 47%) met the
pneumonia surveillance case definition and 4460 children were enrolled (Fig 1). Of those chil-
dren enrolled, 142 were found to be ineligible (17 not age eligible and 125 who had not lived in
the target districts for at least three months), resulting in 4318 children 2–59 months of age
included in the analysis. Of the included children, 24% (1056/4318) were identified by retro-
spective chart review. In children with a known outcome (n = 3265), <1% were reported to
have died during their admission (n = 16).
Table 1. Case definition and pneumonia endpoint definitions used in the pneumonia surveillance program.
Category Criteria
Surveillance case definition
All pneumonia Cough or difficulty breathing, with one of the following:
• an elevated respiratory rate (�50 bpm for all ages)
• oxygen saturation <90%;
• lower chest wall indrawing
Pneumonia endpoint definitions
WHO-defined primary endpoint
pneumonia (PEP)
End-point consolidation (dense or fluffy opacity that occupies a portion or
whole of a lobe or the entire lung that may or may not contain air
bronchograms)
OR pleural effusion that is in the lateral pleural space and associated with
pulmonary parenchymal infiltrate or if the effusion obliterated enough of the
hemithorax to obscure an opacity.
Severe pneumonia (IMCI 2005
criteria [11])
Cough or difficulty breathing and tachypnoea plus
• Lower chest indrawing OR
• General danger sign (inability to breastfeed or drink, persistent vomiting,
lethargy or reduced level of consciousness, convulsions or severe
malnutrition) OR
• Oxygen saturation < 90% or central cyanosis
Very severe pneumonia Severe pneumonia with one or more of the following:
• ICU admission/supplementary oxygen used
• hypoxia (O2 sat < 90%)a
• death
• persistent signs of severe illness post-discharge
• empyema
a Only relevant for severe pneumonia cases classified based on chest indrawing or general danger sign criteria.
https://doi.org/10.1371/journal.pone.0222423.t001
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Pneumonia admissions showed a seasonal pattern (Fig 1) with the highest number of
admissions and enrolments over the winter months (November-March) and the lowest
numbers in summer (June-August). Approximately three quarters (3162/4318, 73%) of all
pneumonia admissions in the enhanced surveillance program were in children 2–23
months of age.
Pneumonia incidence rates
Overall the incidence for all-cause pneumonia in children 2–59 months of age was 31.8
(95% confidence interval [CI] 30.9–32.8) per 1000 population (Table 2). Children aged 2–11
months had an almost four-fold higher incidence (83.7 [95% CI 79.9–87.8] per 1000 popula-
tion) of all-cause pneumonia than children aged 12–59 months (22.4 [95% CI 21.5–23.3]
per 1000 population). A similar difference was seen in PEP (9.2 [95% CI 7.9–10.6] per 1000
for 2–11 months compared with 2.5 [95% CI 2.2–2.8] per 1000 for 12–59 months). The inci-
dence for severe pneumonia was around 19 per 1000 population and very severe pneumonia
8 per 1000 population for all children aged 2–59 months. Incidence rates differed between
the four districts and were generally higher in the Songinokhairkhan and Su¨khbaatar
(“Phase 1”) Districts compared with the Bayanzu¨rkh and Chingeltei (“Phase 2”) Districts in
all age groups (Table 2).
Fig 1. Total pneumonia admissions and children 2–59 months screened and enrolled into the surveillance program, Mongolia, April 2015-May 2016. �Numbers
of children meeting the case definition were not available for April and May 2015, so they were assumed to be equal to enrolments numbers based on experience from
other months.
https://doi.org/10.1371/journal.pone.0222423.g001
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Characteristics of children living in different districts of Ulaanbaatar
Just over half of pneumonia surveillance patients were enrolled in the phase 1 districts of
Ulaanbaatar (2364/4318, 55%). Risk factor questionnaires could not be collected for the
1056 cases enrolled retrospectively by chart review. Risk factor questionnaires were however
undertaken for 95% (3088/3262) of cases prospectively enrolled in the surveillance. Among
these cases, there were some baseline differences observed in the characteristics of enrolled
children residing in phase 1 and phase 2 districts (Table 3). In phase 1 districts 63% (1496/
2364) of pneumonia admissions were enrolled during the cold season (November to March
inclusive), while in phase 2 districts only half of participants (53%, 1038/1954, p<0.001)
were enrolled during this period. In phase 1 districts children were more likely to live in
informal housing (41%, 680/1643) and households that used coal for cooking (69%, 1126/
1642), compared with phase 2 districts (34%, 495/1445 and 56%, 805/1440 respectively).
There were also differences in hospital admission practices, including length of stay, antibi-
otics and oxygen supplementation, and the proportions of severe pneumonia and PEP
between the two districts.
Table 2. Incidence rates for pneumonia by category, age and district, in children 2–59 months of age in Mongolia, April 2015-May 2016 (per 1000 population).
Incidence rate
(95% CI)
All districts
Incidence rate
(95% CI)
Phase 1 districts
Incidence rate
(95% CI)
Phase 2 districts
Incidence rate (95%
CI)
Songinokhair-khan
District
Incidence rate
(95% CI)
Su¨khbaatar
District
Incidence rate (95% CI)
Bayanzu¨rkh District
Incidence rate (95% CI)
Chingeltei District
All pneumonia cases
2–11
months
83.7 (79.9–87.8) 90.9 (85.2–96.9) 76.6 (71.3–82.0) 77.1 (71.0–83.6) 128.5 (115.6–
142.5)
84.9 (78.1–92.1) 61.0 (53.2–69.6)
12–59
months
22.4 (21.5–23.3) 25.1 (23.8–26.5) 19.8 (18.6–20.9) 21.0 (19.6–22.5) 35.0 (32.3–38.0) 18.7 (17.4–20.1) 22.0 (19.9–24.2)
2–59
months
31.8 (30.9–32.8) 35.4 (34.0–36.9) 28.3 (27.1–29.6) 30.0 (28.5–31.6) 48.5 (45.5–51.7) 28.3 (26.8–29.9) 28.4 (26.2–30.7)
Primary endpoint pneumonia cases
2–11
months
9.2 (7.9–10.6) 11.5 (9.5–13.8) 6.9 (5.4–8.7) 11.8 (9.5–14.5) 10.7 (7.2–15.3) 8.1 (6.1–10.5) 4.7 (2.7–7.5)
12–59
months
2.5 (2.2–2.8) 3.3 (2.9–3.8) 1.8 (1.4–2.1) 2.9 (2.4–3.5) 4.3 (3.3–5.4) 1.3 (1.0–1.8) 2.6 (1.9–3.5)
2–59
months
3.6 (3.2–3.9) 4.6 (4.1–5.1) 2.5 (2.2–2.9) 4.4 (3.8–5.0) 5.2 (4.2–6.3) 2.3 (1.9–2.8) 3.0 (2.3–3.8)
Severe pneumonia cases
2–11
months
58.9 (55.6–62.2) 66.4 (61.6–71.6) 51.2 (47.0–55.8) 59.3 (53.9–65.0) 86.0 (75.5–97.6) 61.0 (55.3–67.2) 32.9 (27.2–39.3)
12–59
months
12.0 (11.3–12.6) 13.3 (12.4–14.3) 10.7 (9.8–11.5) 11.6 (10.6–12.7) 17.3 (15.4–19.5) 11.4 (10.4–12.5) 9.0 (7.7–10.5)
2–59
months
19.2 (18.4–19.9) 21.6 (20.5–22.8) 16.8 (15.8–17.8) 19.3 (18.1–20.6) 27.3 (25.0–29.7) 18.6 (17.4–19.9) 12.9 (11.4–14.5)
Very severe pneumonia cases
2–11
months
26.6 (24.5–28.9) 26.6 (23.5–29.9) 26.7 (23.6–30.0) 26.5 (22.9–30.4) 27.1 (21.4–34.0) 32.2 (28.1–36.8) 16.0 (12.2–20.7)
12–59
months
4.8 (4.4–5.3) 5.2 (4.7–5.9) 4.4 (3.9–5.0) 4.3 (3.7–5.0) 4.8 (3.8–5.9) 5.7 (4.9–6.4) 4.4 (3.5–5.4)
2–59
months
8.2 (7.7–8.7) 8.5 (7.8–9.2) 7.9 (7.2–8.6) 7.9 (7.1–8.7) 8.0 (6.8–9.3) 9.5 (8.7–10.4) 6.3 (5.3–7.4)
CI = confidence interval; Phase 1 districts = Songinokhairkhan District and Su¨khbaatar District; Phase 2 Districts = Bayanzu¨rkh District and Chingeltei District
https://doi.org/10.1371/journal.pone.0222423.t002
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Table 3. Characteristics of children 2–59 months of age living in the Phase 1 (Songinokhairkhan and Su¨khbaatar) and Phase 2 (Bayanzu¨rkh and Chingeltei) districts
prior to PCV13 introduction in Mongolia, April 2015 to May 2016 (n = 4318).
Category Sub-category Case numbers n/N (%) Chi squared p-value
Phase 1 districts (SK/SBa) Phase 2 districts (CHD/BZa)
Sex Female 1066/2364 (45) 887/1954 (45)
Male 1298/2364 (55) 1067/1954 (55) 0.84
Age 2–11 months 948/2364 (74) 798/1954 (73)
12–59 months 1416/2364 (26) 1156/1954 (27) 0.54
Seasonb Cold season 1496/2364 (63) 1038/1954 (53) <0.001
Warm season 868/2364 (37) 916/1954 (47)
Primary caregiver Parent 1474/1643 (90) 1319/1445 (91) 0.14
Not parent 169/1643 (10) 126/1445 (9)
Mothers education Tertiary 822/1635 (50) 772/1431 (54) 0.04
Primary/Secondary 813/1635 (50) 659/1431 (46)
Number of siblings Any siblings 558/1639 (34) 369/1440 (26) <0.001
No siblings 1081/1639 (66) 1071/1440 (74)
Crowding (People/room) >3 491/1623 (30) 355/1413 (25) 0.002
< = 3 1132/1623 (70) 1058/1413 (75)
Smokers in the home Yes 736/1642 (45) 584/1443 (40) 0.02
No 906/1642 (55) 859/1443 (60)
Fuel for cooking Wood/Coal 1126/1642 (69) 805/1440 (56) <0.001
Electricity/gas 516/1642 (31) 635/1440 (44)
Housing type Informal 680/1643 (41) 495/1445 (34) <0.001
Formal 963/1643 (59) 950/1445 (66)
Khoro (subdistrict) typec Ger 799/1729 (46) 741/1444 (51)
Apartment 295/1729 (17) 269/1444 (19)
Mixed 635/1729 (37) 434/1444 (30) <0.001
Household income At/below minimum 631/1549 (41) 313/1386 (23) <0.001
Above minimum 918/1549 (59) 1073/1386 (77)
Household member treated for tuberculosis Yes 10/1626 (1) 28/1395 (2) 0.001
No 1616/1626 (99) 1367/1395 (98)
Breastfeeding Yes 985/1641 (60) 715/1446 (51) <0.001
No 656/1641 (40) 731/1446 (49)
Asthma Yes 172/1635 (11) 131/1430 (9) 0.21
No 1463/1635 (89) 1299/1430 (91)
Length of hospital stay (days) < = 7 1939/2363 (82) 1405/1953 (72) <0.001
>7 424/2363 (18) 548/1953 (28)
Any previous admission Yes 758/1624 (47) 631/1437 (44) 0.13
No 866/1624 (53) 806/1437 (56)
Antibiotic given in hospital Yes 1876/1994 (94) 1484/1624 (91) 0.002
No 118/1994 (6) 140/1624 (9)
O2 supplementation Yes 579/2314 (25) 526/1862 (28) 0.02
No 1735/2314 (75) 1336/1862 (72)
Hypoxia (O2 saturation <90%) Yes 431/2156 (20) 448/1717 (26) <0.001
No 1725/2156 (80) 1269/1717 (74)
Severe pneumonia Yes 1443/2364 (61) 1158/1954 (59) 0.24
No 921/2364 (39) 796/1954 (41)
Very severe pneumonia Yes 527/2364 (22) 584/1954 (30) <0.001
No 1837/2364 (78) 1370/1954 (70)
(Continued)
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Primary endpoint pneumonia
A total of 2878 (67%) of the enrolled children had CXR results over the baseline period and
only 75 (3%) of these were uninterpretable. Of the interpretable CXRs (n = 2803), 483 (17%)
showed PEP, either alveolar consolidation or pleural effusions, 874 (31%) showed other infil-
trates and 1446 (52%) showed no consolidation. The proportion of PEP, combined across age
groups and sites, varied across the baseline period between 8% and 28% (Fig 2) with the high-
est proportions observed in June 2015 (summer) and December 2015 (winter).
Characteristics and risk factors were compared between pneumonia cases who had PEP
detected on CXR and those who had normal CXRs with no abnormalities detected as these
were the two most reliable endpoints (S1 Table). Differences were found by district, with chil-
dren with pneumonia from Sukhbaatar (aOR 2.01, 95% CI 1.41–2.87), Songinokhairkhan
(aOR 3.66, 95% CI 2.65–5.07) and Chingeltei (aOR 2.24, 95% CI 1.48–3.40) all more likely to
have PEP on CXR than those from Bayanzu¨rkh. Children with a hospital stay of less than 7
days (aOR 0.57, 95% CI 0.43–0.75) were less likely to have PEP on their CXRs than those with
longer stays. CXRs were more likely to show PEP in children from crowded households (aOR
1.35, 95% CI 1.04–1.77) with siblings (aOR 1.36, 95% CI 1.05–1.77), in children with a history
of a previous admission in the last 10 days (aOR 1.68, 95% CI 1.15–2.45), in children with mal-
nutrition (aOR 2.30, 95% CI 1.40–3.79) and in children with very severe pneumonia (aOR
1.76, 95% CI 1.35–2.30).
Sensitivity analysis
CXRs were available for 67% (2878/4318) of children. On sensitivity analysis, using imputed
case numbers for PEP incidence rates (S2 Table), the trend towards a higher incidence of PEP
hospitalizations in district 1 hospitals remained in all age groups. Using multiple imputation,
the incidence for children in all districts aged 2–11 months (12.0 [95% CI 10.6–13.6] per 1000
population) was nearly four-fold higher than that for children aged 12–59 months (3.3 [95%
CI 3.0–3.6] per 1000 population).
Discussion
This study describes results from a large series of pneumonia cases among children aged 2–59
months in Ulaanbaatar, Mongolia, prior to PCV13 introduction. Rates of pneumonia were
higher in young children (aged 2–11 months) compared with older children (aged 12–59
months) and generally higher in the Songinokhairkhan and Su¨khbaatar (“Phase 1”) Districts
compared with the other two districts. In addition children in phase 1 districts were more
likely to have certain risk factors for pneumonia, including more siblings, exposure to coal for
cooking, cigarette smoke in the home and a lower household income, than phase 2 districts.
Table 3. (Continued)
Category Sub-category Case numbers n/N (%) Chi squared p-value
Phase 1 districts (SK/SBa) Phase 2 districts (CHD/BZa)
Primary endpoint pneumonia Yes 308/1521 (20) 175/1282 (14) <0.001
No 1213/1521 (80) 1107/1282 (86)
a SK = Songinokhairkhan District, SB = Su¨khbaatar District, BZ = Bayanzu¨rkh District, CHD = Chingeltei District.
b Cold season refers to the winter months (Nov-March) and warm season refers to non-winter months.
c Khoros are sub-districts that are categorized according to the predominant housing type, either ger (traditional Mongolian housing), apartment or mixed (ger and
apartments).
https://doi.org/10.1371/journal.pone.0222423.t003
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Pneumonia in Mongolia is highly seasonal and increases in hospital admissions usually cor-
respond to the winter season. Severe acute respiratory infection (SARI) surveillance in Mongo-
lia demonstrated peaks in SARI cases between October and December and between January
and March [12]. In 2015/2016 the coldest months were from December 2015 to February
2016. In our study we observed an increase in pneumonia hospitalizations in February and
March 2016 which also corresponded to an increase in circulating respiratory syncytial virus
detected by study testing, as well as influenza virus detected by routine surveillance in Mongo-
lia [13].
The incidence of all-cause pneumonia for children 2–59 months was 31.8 per 1000 popula-
tion while that for severe pneumonia was 19.2 per 1000 population. The severe pneumonia
estimates are similar to those reported by a 2015 global burden model for Mongolia which
reported an incidence of 21 (8-51) per 1000 in children <5 years of age [14]. Our estimate of
3.6 (3.2–3.9) per 1000 population for PEP is similar to that found in a Fiji study (4.3 (3.5–5.3)
per 1000). The Fiji study was also conducted prior to PCV introduction and included children
from 1–59 months of age [15]. Younger children aged 2–11 months had a much higher inci-
dence of pneumonia which may be due to a higher burden of disease, but also due to the fact
that younger children are more likely to be admitted.
A randomized vaccine-probe trial from Indonesia identified 28,503 cases of clinical pneu-
monia; 3308 were severe pneumonia cases that were hospitalized and of the 3171 that had
Fig 2. Radiology results and proportion of chest X-rays showing primary endpoint pneumonia by month for children 2–59 months, Mongolia, April 2015-May
2016 (n = 2803).
https://doi.org/10.1371/journal.pone.0222423.g002
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CXRs, 22% were radiologically-confirmed based on the WHO case definition [16]. A study
from the Pacific region showed that 34% of children admitted with pneumonia had PEP [15].
In our study 17% of children with CXRs had PEP. The proportion of PEP varied across the
baseline period (between 8% and 28%) and didn’t seem directly related to season. These varia-
tions may be related to other factors such as differences in admission criteria and bed availabil-
ity at different times of the year, as PEP cases differed from cases with normal CXR in terms of
district and disease severity.
Several studies have suggested that bacterial pneumonia cannot be differentiated from non-
bacterial pneumonia on the basis of the chest radiograph. However some studies have shown
that bacterial, especially pneumococcal infections, are more frequently detected in patients
with radiologically confirmed pneumonia compared with normal CXRs [17–19].
There were some baseline differences in the characteristics of children enrolled in the phase
1 and phase 2 districts of Ulaanbaatar. These differences included both socio-economic factors,
such as housing type and crowding, as well as clinical presentation, antibiotic prescription and
oxygen delivery. It will be important to adjust for district-level differences when we assess the
impact of PCV13 in this setting. A previous study exploring risk factors for lower respiratory
tract infections in rural Mongolia [20] found that smoking in the home, low birthweight and
being a male child increased the likelihood of pneumonia admission while exclusive breast-
feeding for more than 4 months and an unwillingness to seek healthcare was associated with a
lower likelihood of admission.
Our surveillance program had a number of strengths. The program is population-based
and includes a large number of children, which provides robust baseline estimates against
which to measure PCV impact in Mongolia. Most people in Ulaanbaatar access healthcare in
the public sector so our surveillance is likely representative of the general population. The
Mongolian MOH chose to introduce PCV in a graded fashion into Ulaanbaatar, which will
enable us to compare vaccinated and unvaccinated populations concurrently, rather than only
pre- and post-PCV comparisons.
There were a number of limitations in our study. Firstly, a number of cases were missed in
2015 when the surveillance program was first started. Cases that were missed were enrolled ret-
rospectively. Even though good medical records were available, there was some missing data
for these cases and CXRs were usually not available for these children. When we imputed miss-
ing data, however, our primary findings did not change overall. The results without imputa-
tion are likely an underestimate; additional “PEP” cases are added with the imputation so all
incidence estimates are increased. Secondly, during study start-up and implementation the
updated WHO case definition, which excluded chest indrawing as a severe sign for pneumonia
hospitalization, was introduced into hospitals in Ulaanbaatar. For the surveillance program
however we used a standard case definition for enrolment and set definitions for severe and
very severe pneumonia. In addition our primary study endpoint was PEP. Our enrolment case
definition was an adapted WHO case definition and hospital doctors indicated that they still
admitted children with chest indrawing after the WHO case definition changed. It is therefore
unlikely that this change would have influenced our case numbers significantly. Thirdly, our
incidence calculations may be an underestimation of case numbers as only some cases will
present to health facilities and be admitted. However, in Mongolia, hospital care for children is
free of charge and there is a low threshold for admission of children, so it is unlikely that severe
cases were missed unless they died prior to admission. In addition given the urban setting of
the evaluation we consider it unlikely that geographical barriers prevented health care seeking.
However, we may have underestimated very severe pneumonia incidence rates as oxygen ther-
apy was considered to be a proxy for ICU admissions which were not directly recorded.
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In conclusion we have shown a high burden of pneumonia in children <5 years of age in
Mongolia prior to the introduction of PCV. Rates differed somewhat by district and age group
and were influenced by a number of socio-economic factors. It will be important to consider
these differences and risk factors when assessing the impact of PCV post-introduction.
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